200 related articles for article (PubMed ID: 25684464)
1. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis.
Chen WJ; He DS; Tang RX; Ren FH; Chen G
Asian Pac J Cancer Prev; 2015; 16(2):411-20. PubMed ID: 25684464
[TBL] [Abstract][Full Text] [Related]
2. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
Petrelli F; Viale G; Cabiddu M; Barni S
Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
[TBL] [Abstract][Full Text] [Related]
4. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.
Pan D; Wei K; Ling Y; Su S; Zhu M; Chen G
Med Sci Monit; 2015 Mar; 21():882-9. PubMed ID: 25807305
[TBL] [Abstract][Full Text] [Related]
6. Radiomic features predict Ki-67 expression level and survival in lower grade gliomas.
Li Y; Qian Z; Xu K; Wang K; Fan X; Li S; Liu X; Wang Y; Jiang T
J Neurooncol; 2017 Nov; 135(2):317-324. PubMed ID: 28900812
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.
Li C; Sun J; Xiang Q; Liang Y; Zhao N; Zhang Z; Liu Q; Cui Y
J Neurooncol; 2016 Oct; 130(1):11-17. PubMed ID: 27531352
[TBL] [Abstract][Full Text] [Related]
9. Is Overexpression of Ki-67 a Prognostic Biomarker of Upper Tract Urinary Carcinoma? A Retrospective Cohort Study and Meta-Analysis.
Fan B; Zhang H; Jin H; Gai Y; Wang H; Zong H; Jin M; Yang H; Wan S; Zhu J; Xu S; Wang J; Yang D; Song X
Cell Physiol Biochem; 2016; 40(6):1613-1625. PubMed ID: 28006766
[TBL] [Abstract][Full Text] [Related]
10. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of vascular endothelial growth factor indicates poor outcomes of glioma: a systematic review and meta-analysis.
Chen W; He D; Li Z; Zhang X; Pan D; Chen G
Int J Clin Exp Med; 2015; 8(6):8709-19. PubMed ID: 26309522
[TBL] [Abstract][Full Text] [Related]
12. BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis.
Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Fung KM; Hassell L
Mol Neurobiol; 2018 May; 55(5):3718-3724. PubMed ID: 28534272
[TBL] [Abstract][Full Text] [Related]
13. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and Prognostic Roles of STAT3 and Its Phosphorylation in Glioma.
Liang B; Li SY; Gong HZ; Wang LX; Lu J; Zhao YX; Gu N
Dis Markers; 2020; 2020():8833885. PubMed ID: 33299498
[TBL] [Abstract][Full Text] [Related]
15. Ki-67: a prognostic factor for low-grade glioma?
Fisher BJ; Naumova E; Leighton CC; Naumov GN; Kerklviet N; Fortin D; Macdonald DR; Cairncross JG; Bauman GS; Stitt L
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):996-1001. PubMed ID: 11958894
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of survivin in patients with glioma.
Zhang S; Zhang C; Song Y; Zhang J; Xu J
Medicine (Baltimore); 2018 Apr; 97(17):e0571. PubMed ID: 29703049
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Ahn C; Jeong CW; Kwak C; Kim HH; Kim HS; Ku JH
Clin Genitourin Cancer; 2018 Aug; 16(4):e831-e841. PubMed ID: 29551582
[TBL] [Abstract][Full Text] [Related]
18. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control.
Yuan Y; Xiang W; Yanhui L; Ruofei L; Shuang L; Yingjun F; Qiao Z; Yanwu Y; Qing M
Seizure; 2013 Dec; 22(10):877-81. PubMed ID: 23992787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
